BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-ladner U, Niehues T, Überla K, Vygen-bonnet S, Weinke T, Wiese-posselt M, Wojcinski M, Zepp F. Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie. Bundesgesundheitsbl 2019;62:494-515. [DOI: 10.1007/s00103-019-02905-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 27] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Stangel M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Hunter ZR, Kallmann B, Kleinschnitz C, Klotz L, Leussink V, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber MS, Weber F, Zettl UK, Ziemssen T, Zipp F; die Multiple Sklerose Therapie Konsensus Gruppe (MSTKG). [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Nervenarzt 2021;92:773-801. [PMID: 34297142 DOI: 10.1007/s00115-021-01157-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Stephan B, Tittelbach J, Bühler S. Reisevorbereitungen für Patienten mit Psoriasis unter Immunsuppression. J Dtsch Dermatol Ges 2021;19:197-208. [PMID: 33586903 DOI: 10.1111/ddg.14377_g] [Reference Citation Analysis]
3 Osmani V, Klug SJ. [HPV vaccination and the prevention of genital warts and precancerous lesions-current evidence and evaluation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021;64:590-9. [PMID: 33851224 DOI: 10.1007/s00103-021-03316-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kromer C, Wellmann P, Siemer R, Klein S, Mohr J, Pinter A, Wilsmann-Theis D, Mössner R. Influenza Vaccination in Psoriatic Patients-Epidemiology and Patient Perceptions: A German Multicenter Study (Vac-Pso). Vaccines (Basel) 2021;9:843. [PMID: 34451968 DOI: 10.3390/vaccines9080843] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Christenn M. [Immunogenicity and safety of high dose vs. standard dose of inactivated influenza vaccine in patients with rheumatoid arthritis]. Z Rheumatol 2021. [PMID: 34170415 DOI: 10.1007/s00393-021-01030-2] [Reference Citation Analysis]
6 Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Kallmann B, Kleinschnitz C, Klotz L, Leussink VI, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber F, Weber MS, Zettl UK, Ziemssen T, Zipp F; ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG). Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Ther Adv Neurol Disord 2021;14:17562864211039648. [PMID: 34422112 DOI: 10.1177/17562864211039648] [Reference Citation Analysis]
7 Freudenhammer M, Hufnagel M. [Travelling with children and adolescents with rheumatic diseases]. Z Rheumatol 2021;80:620-8. [PMID: 33904986 DOI: 10.1007/s00393-021-01002-6] [Reference Citation Analysis]
8 Kleine-Tebbe J, Klimek L, Hamelmann E, Pfaar O, Taube C, Wagenmann M, Werfel T, Worm M. Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences. Allergol Select 2021;5:26-8. [PMID: 33426427 DOI: 10.5414/ALX02215E] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
9 Krasselt M, Baerwald C, Liebert UG, Seifert O. Humoral Immunity to Varicella Zoster Virus in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Compared to Healthy Controls. Vaccines (Basel) 2021;9:325. [PMID: 33915820 DOI: 10.3390/vaccines9040325] [Reference Citation Analysis]
10 Pfaar O, Klimek L, Hamelmann E, Kleine-Tebbe J, Taube C, Wagenmann M, Werfel T, Brehler R, Novak N, Mülleneisen N, Becker S, Worm M. COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA). Allergol Select 2021;5:140-7. [PMID: 33842829 DOI: 10.5414/ALX02241E] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Blanchard-Rohner G. Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide. Front Immunol 2021;12:711637. [PMID: 34408752 DOI: 10.3389/fimmu.2021.711637] [Reference Citation Analysis]
12 Schreiner D, Zepp F. [General principles of vaccination under immunosuppression]. Z Rheumatol 2020;79:848-54. [PMID: 33034682 DOI: 10.1007/s00393-020-00891-3] [Reference Citation Analysis]
13 Welzel T, Benseler SM, Kuemmerle-Deschner JB. Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood. Front Immunol 2021;12:516427. [PMID: 33868220 DOI: 10.3389/fimmu.2021.516427] [Reference Citation Analysis]
14 Kiltz U, Celik A, Tsiami S, Baraliakos X, Andreica I, Kiefer D, Bühring B, Braun J. [How well are patients with inflammatory rheumatic diseases protected against measles?]. Z Rheumatol 2020;79:912-21. [PMID: 32930874 DOI: 10.1007/s00393-020-00874-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Winkelmann A, Löbermann M, Zettl UK. Varicella-zoster- und Herpes-zoster-Impfindikation bei Multipler Sklerose: aktuelle Situation. Nervenarzt 2019;90:1254-60. [DOI: 10.1007/s00115-019-00806-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
16 Pfrepper C, Holstein K, Königs C, Heller C, Krause M, Olivieri M, Bidlingmaier C, Sigl-Kraetzig M, Wendisch J, Halimeh S, Horneff S, Richter H, Wieland I, Klamroth R, Oldenburg J, Tiede A; Hemophilia Board of the German, Austrian, Swiss Society on Thrombosis Hemostasis Research (GTH). Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia. Hamostaseologie 2021;41:190-6. [PMID: 33860513 DOI: 10.1055/a-1401-2691] [Reference Citation Analysis]
17 Seybold U. [61/m-Fresh following corona infection : Preparation for the medical specialist examination: part 14]. Internist (Berl) 2021;62:81-5. [PMID: 33416913 DOI: 10.1007/s00108-020-00929-3] [Reference Citation Analysis]
18 Nast A, Smith C, Spuls P, Avila Valle G, Bata‐csörgö Z, Boonen H, De Jong E, Garcia‐doval I, Gisondi P, Kaur‐knudsen D, Mahil S, Mälkönen T, Maul J, Mburu S, Mrowietz U, Reich K, Remenyik E, Rønholt K, Sator P, Schmitt‐egenolf M, Sikora M, Strömer K, Sundnes O, Trigos D, Van Der Kraaij G, Yawalkar N, Dressler C. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol 2021;35:281-317. [DOI: 10.1111/jdv.16926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Bogdan C. [STIKO vaccination recommendations : Vaccination of immunodeficient patients and vaccination against COVID-19]. Hautarzt 2021;72:92-9. [PMID: 33462654 DOI: 10.1007/s00105-021-04761-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ehren R, Benz MR, Brinkkötter PT, Dötsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, Müller D, Oh J, Tönshoff B, Weber S, Weber LT; German Society for Pediatric Nephrology. Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020. Pediatr Nephrol 2021;36:2971-85. [PMID: 34091756 DOI: 10.1007/s00467-021-05135-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, Iking-Konert C, Kreuter A, Müller-Ladner U, Nast A, Ochsendorf F, Schneider M, Sticherling M, Tenbrock K, Wenzel J, Kuhn A. S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes - Teil 2: Therapie, Risikofaktoren und spezielle Fragestellungen. J Dtsch Dermatol Ges 2021;19:1371-95. [PMID: 34541800 DOI: 10.1111/ddg.14491_g] [Reference Citation Analysis]
22 Kneitz C, Müller-Ladner U. [Most important vaccinations in patients with rheumatological diseases and why]. Z Rheumatol 2020;79:855-64. [PMID: 32955610 DOI: 10.1007/s00393-020-00875-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.Dtsch Arztebl Int. 2020;117:564-574. [PMID: 33148393 DOI: 10.3238/arztebl.2020.0564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Stephan B, Tittelbach J, Bühler S. Considerations for patients with psoriasis travelling under immunosuppression. J Dtsch Dermatol Ges 2021;19:197-207. [PMID: 33491922 DOI: 10.1111/ddg.14377] [Reference Citation Analysis]
25 Seitel T, Cagol L, Prelog M, Frivolt K, Krahl A, Trenkel S, Speth F, Mayer B, Almanzar G, Koletzko S, Debatin KM, Mertens T, Posovszky C. Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: A prospective observational study. Vaccine 2020;38:8024-31. [PMID: 33160754 DOI: 10.1016/j.vaccine.2020.10.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mohme S, Schmalzing M, Müller CSL, Vogt T, Goebeler M, Stoevesandt J. Immunizations in immunocompromised patients: a guide for dermatologists. J Dtsch Dermatol Ges 2020;18:699-723. [PMID: 32713146 DOI: 10.1111/ddg.14156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, Iking-Konert C, Kreuter A, Müller-Ladner U, Nast A, Ochsendorf F, Schneider M, Sticherling M, Tenbrock K, Wenzel J, Kuhn A. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 2: Therapy, risk factors and other special topics. J Dtsch Dermatol Ges 2021. [PMID: 34338428 DOI: 10.1111/ddg.14491] [Reference Citation Analysis]
28 Wendt S, Trawinski H, Pietsch C, Borte M, Lübbert C. [Vaccinations]. Internist (Berl) 2021. [PMID: 34709421 DOI: 10.1007/s00108-021-01193-9] [Reference Citation Analysis]
29 Bühler S, Jaeger VK, Eperon G, Furrer H, Fux CA, Jansen S, Neumayr A, Rochat L, Schmid S, Schmidt-Chanasit J, Staehelin C, de Visser AW, Visser LG, Niedrig M, Hatz C. Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy-a prospective multi-centre pilot study1. J Travel Med 2020;27:taaa126. [PMID: 32729905 DOI: 10.1093/jtm/taaa126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Pfaar O, Klimek L, Hamelmann E, Kleine-Tebbe J, Taube C, Wagenmann M, Werfel T, Brehler R, Novak N, Mülleneisen NK, Becker S, Worm M. COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika): Ein Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und dem Ärzteverband Deutscher Allergologen (AeDA). Allergo J 2021;30:24-33. [PMID: 34393383 DOI: 10.1007/s15007-021-4846-1] [Reference Citation Analysis]
31 Wiestler M, Seidler U. Mit Morbus Crohn und Colitis ulcerosa sicher durch die Schwangerschaft. Geburtshilfe Frauenheilkd 2022;82:34-8. [DOI: 10.1055/a-1430-4878] [Reference Citation Analysis]
32 Kiltz U, Celik A, Tsiami S, Buehring B, Baraliakos X, Andreica I, Kiefer D, Braun J. Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study. RMD Open 2021;7:e001499. [PMID: 33832974 DOI: 10.1136/rmdopen-2020-001499] [Reference Citation Analysis]
33 Laws HJ, Baumann U, Bogdan C, Burchard G, Christopeit M, Hecht J, Heininger U, Hilgendorf I, Kern W, Kling K, Kobbe G, Külper W, Lehrnbecher T, Meisel R, Simon A, Ullmann A, de Wit M, Zepp F. Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020;63:588-644. [PMID: 32350583 DOI: 10.1007/s00103-020-03123-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 7.5] [Reference Citation Analysis]